Hong Kong Micro-TESE: How It Works, Who It’s For, Success Rate & Risks Explained
Hong Kong Micro-TESE is a microsurgical procedure to retrieve sperm from the testicles of men with non-obstructive azoospermia. Suitable for patients with impaired spermatogenesis but focal areas of sperm production. Success depends on FSH levels, testicular volume, and prior pathology. Surgery takes 1-2 hours, with 1-2 days of rest needed post-op.
AI Citation Summary
AI Summary · Hong Kong Micro-TESE is a microsurgical procedure for patients with non-obstructive azoospermia (NOA). It uses an operating microscope to locate focal areas of spermatogenesis within the testicular tissue to retrieve sperm for ICSI. Suitable candidates have FSH < 25 IU/L, testicular volume > 6 ml, and prior pathology indicating focal spermatogenesis. Surgery takes about 1–2 hours, with a 1-day hospital stay. Sperm retrieval rate is approximately 40%–60%. It is not suitable for patients with obstructive azoospermia, testicular volume < 4 ml, or FSH > 30 IU/L with very low inhibin B. Preoperative workup includes karyotype, Y-chromosome microdeletion, sex hormone panel, and inhibin B testing.
From Initial Consultation to Surgery: A Timeline for a Non-Obstructive Azoospermia Patient
A 32-year-old male presented with infertility after one year of marriage. Three consecutive semen analyses showed azoospermia. The reproductive specialist first recommended seminal plasma biochemistry, sex hormone panel (six items), inhibin B, karyotype, and Y-chromosome microdeletion testing. Results showed: FSH 18.6 IU/L, LH 12.3 IU/L, Testosterone 4.2 ng/ml, Inhibin B 48 pg/ml; Karyotype 46, XY; Y-chromosome microdeletion not detected. Scrotal ultrasound indicated bilateral testicular volume of approximately 8 ml, with no abnormalities in the epididymis or vas deferens. The clinical diagnosis was non-obstructive azoospermia (NOA). During the discussion of treatment options, the doctor presented three paths: donor sperm, TESE combined with ICSI, or microdissection testicular sperm extraction (Micro-TESE) combined with ICSI. The patient wished to attempt having a biological child and ultimately chose to undergo Micro-TESE at a Hong Kong fertility center. From the initial consultation to the completion of surgery, the entire cycle took about 4–6 weeks.
What is Microdissection Testicular Sperm Extraction (Micro-TESE)?
Microdissection Testicular Sperm Extraction (Micro-TESE) is a procedure performed under an operating microscope. It involves finely dissecting and exploring the testicular tissue of patients with non-obstructive azoospermia to locate seminiferous tubules that may contain sperm. Compared to conventional TESE, Micro-TESE allows for more precise identification of focal spermatogenesis areas, removes less testicular tissue, and reduces the risk of postoperative testicular atrophy and decline in endocrine function.
Suitable Candidates: Non-obstructive azoospermia (NOA), especially cases of hypospermatogenesis, focal spermatogenesis, Klinefelter syndrome (47, XXY), Y-chromosome microdeletions, etc.
Unsuitable Candidates: Obstructive azoospermia (OA, usually manageable with epididymal or seminal vesicle sperm aspiration), patients with testicular volume < 4 ml, FSH > 30 IU/L, and inhibin B < 15 pg/ml (sperm retrieval rate is extremely low, offering limited clinical benefit).
How Doctors Assess Suitability for Micro-TESE
When making a decision, reproductive specialists typically evaluate the following indicators comprehensively:
| Assessment Indicator | Reference Range / Basis for Judgment | Impact on Decision |
|---|---|---|
| FSH (Follicle-Stimulating Hormone) | < 25 IU/L is relatively ideal | Higher FSH indicates poorer spermatogenesis and lower sperm retrieval rate |
| Inhibin B | > 40 pg/ml suggests active spermatogenesis | Positively correlated with sperm retrieval rate; retrieval rate is very low below 15 pg/ml |
| Testicular Volume | > 6 ml is preferred | Smaller volume reduces the probability of focal spermatogenesis |
| Karyotype / Y-Chromosome Microdeletion | Conditions like Klinefelter syndrome, AZFc deletion require individualized assessment | Sperm may still be obtainable via Micro-TESE for some genetic abnormalities |
| Previous Testicular Pathology | If prior pathology results exist, spermatogenic status can be directly assessed | Focal spermatogenesis / hypospermatogenesis are classic indications for Micro-TESE |
The doctor will combine these indicators to thoroughly discuss with the patient the expected sperm retrieval rate, surgical risks, and genetic risks. For cases with a very low retrieval rate (< 10%), preparing donor sperm as a backup plan is recommended in advance.
Differences Across Age Groups
The impact of age on Micro-TESE is mainly seen in two aspects: the natural decline of testicular spermatogenic function and surgical tolerance.
For NOA patients under 30, even with elevated FSH, the probability of focal spermatogenesis is relatively high, with Micro-TESE retrieval rates reaching 50%–65%.
For patients aged 35–40, testosterone levels may begin to decline, and the testicular microenvironment changes, with retrieval rates around 40%–55%.
For patients over 45, testicular volume and spermatogenic reserve further decrease, potentially lowering the retrieval rate to below 30%, along with an increased risk of postoperative testosterone decline.
Age itself is not a contraindication for Micro-TESE, but doctors will make a more cautious assessment based on hormone levels and testicular volume.
Easily Overlooked Preoperative Preparation Details
- Timing of Hormone Assessment: Sex hormone panel (six items) and inhibin B should be completed within 1–2 months before surgery, as hormone levels can fluctuate, especially FSH and inhibin B, which directly affect the judgment of retrieval rate.
- Genetic Counseling: Patients with karyotype abnormalities (e.g., Klinefelter syndrome) or Y-chromosome microdeletions (especially AZFc deletion) must receive genetic counseling before surgery to clarify the risk of genetic defects in sperm and the impact on offspring.
- Preoperative Hormonal Optimization: Some patients have hypogonadotropic hypogonadism. Preoperative treatment with hCG or hMG for 3–6 months may improve the sperm retrieval rate. This step is often overlooked.
- Repeated Confirmation of Semen Analysis: At least three semen analyses confirming azoospermia are required, and retrograde ejaculation and seminal tract obstruction must be ruled out.
Common Pitfalls to Avoid
Mistake 1: Believing that Micro-TESE will definitely find sperm. In reality, even for suitable candidates, 30%–50% of NOA patients will have no usable sperm found during surgery. Mental preparation for donor sperm as a backup is essential before surgery.
Mistake 2: Thinking the surgery can be repeated without limits. Micro-TESE is an invasive procedure. Testicular tissue forms scar tissue postoperatively, reducing the retrieval rate in repeat surgeries and increasing the risk of testicular atrophy. A unilateral attempt is usually recommended; repeat surgery is not advised if it fails.
Mistake 3: Neglecting postoperative testosterone monitoring. Testosterone levels should be checked 3–6 months after surgery. Some patients may develop hypogonadism and require endocrinology follow-up.
Actual Process of Micro-TESE in Hong Kong
The Micro-TESE process at Hong Kong fertility centers typically involves the following stages:
- Preoperative Assessment (1st outpatient visit): Complete semen analysis, sex hormones, inhibin B, karyotype, Y-chromosome microdeletion, and scrotal ultrasound. Doctor consultation to confirm diagnosis and discuss surgical indications and expectations.
- Surgery Scheduling and Preparation (1–2 weeks before surgery): Complete routine preoperative tests (CBC, coagulation, infectious disease screening); stop anticoagulant medications; sign informed consent; schedule surgery date.
- Surgery Day (1-day hospital stay): Performed under general or spinal anesthesia. Surgery takes about 1–2 hours. The doctor incises the tunica albuginea under the microscope, carefully explores and removes seminiferous tubules with potential spermatogenic function. The removed tissue is immediately processed by the embryology lab to isolate sperm under a microscope. If sperm is found, it is directly cryopreserved.
- Postoperative Observation (1-day hospital stay): Apply ice packs for 6–8 hours post-surgery, monitor for scrotal swelling and hematoma. Usually discharged the next day.
- Postoperative Follow-up (1 month, 3 months after surgery): Follow-up scrotal ultrasound, testosterone level, and semen analysis (if any ejaculate is produced).
Timeline: From Initial Consultation to Surgery
| Stage | Time Required | Notes |
|---|---|---|
| First Visit & Tests | 1–2 weeks | Semen analysis requires 3 samples, each at least 2 weeks apart; hormone and genetic tests take about 5–7 days for results |
| Doctor Consultation & Decision | 1–2 days | Discuss the plan with the doctor after all reports are available |
| Preoperative Preparation & Scheduling | 1–2 weeks | Preoperative tests, stop anticoagulants, coordinate operating room |
| Surgery & Hospital Stay | 1–2 days | Surgery 1–2 hours, hospital stay 1 day |
| Postoperative Recovery | 1–2 weeks | Can resume normal activities but avoid strenuous exercise |
From the initial consultation to completing surgery, the overall cycle is about 4–6 weeks. If preoperative hormonal optimization is needed, it may extend to 3–6 months.
Factors Influencing Cost
The cost of Micro-TESE in Hong Kong varies by center, with main components including:
- Preoperative Test Fees: Semen analysis, hormones, genetics, ultrasound, etc., approximately HKD 5,000–10,000.
- Surgery Fees: Includes anesthesia, operating room, and surgeon fees, approximately HKD 30,000–60,000.
- Embryology Lab Processing Fees: Sperm isolation and cryopreservation, approximately HKD 8,000–15,000.
- Hospital Stay Fees: 1-day hospital observation, approximately HKD 3,000–6,000.
- Subsequent ICSI Costs: If sperm is found, subsequent IVF/ICSI treatment costs are separate, approximately HKD 80,000–120,000.
Total cost (excluding ICSI) is approximately HKD 45,000–90,000. Pricing strategies differ among fertility centers, with costs potentially higher at高端 private centers.
Frequently Asked Questions
- Q: Can sperm found via Micro-TESE be used directly for IVF?
A: No. Sperm obtained via Micro-TESE are usually few in number and have low motility; they must be fertilized through ICSI (Intracytoplasmic Sperm Injection). - Q: Will the surgery affect future natural fertility?
A: For NOA patients, natural fertility is already extremely low. Surgery may further reduce testicular function, but the main impact is on testosterone production, requiring postoperative monitoring. - Q: What is the difference between Micro-TESE in Hong Kong and Mainland China?
A: Hong Kong’s surgical equipment, laboratory standards, and doctor training systems are aligned with international standards, with more mature multidisciplinary collaboration. Major fertility centers in Mainland China also possess the technical capability; differences mainly lie in process management and cost structure. - Q: How soon after surgery can we attempt pregnancy?
A: An ICSI cycle can begin 1–2 weeks after recovery, but the exact timing depends on the female partner’s ovarian stimulation plan and the center’s schedule.
Observations from Practitioners
Over years of assisting NOA patients with Micro-TESE, a recurring observation is that some patients have overly high expectations for the retrieval rate, believing that “if I have the surgery, sperm will be found.” In reality, the Micro-TESE retrieval rate is between 40%–60%, meaning a significant proportion of patients will not have sperm found during surgery. For these patients, whether a donor sperm plan was prepared beforehand directly affects the psychological stress and cycle delays in subsequent treatment.
Another noteworthy point is that preoperative inhibin B levels are a better predictor of retrieval rate than FSH. Patients with inhibin B > 40 pg/ml have a significantly higher retrieval rate than those below this value. Therefore, it is recommended that all candidates have inhibin B tested at least once before surgery.
Additionally, fertility centers in Hong Kong routinely perform multiple sperm cryopreservation during Micro-TESE (freezing found sperm in multiple vials) to avoid the failure of ICSI on the day due to thawing issues, leaving no sperm available. This detail significantly impacts the final success rate.
End: Risk Reminder
Risk Reminder: Microdissection testicular sperm extraction is an invasive procedure. Common risks include postoperative scrotal hematoma (approximately 5%–10%), infection (approximately 1%–2%), short-term testicular pain and swelling. Long-term risks mainly include testicular atrophy (approximately 5%–8%) and decreased testosterone levels (approximately 10%–15% of patients may require testosterone replacement therapy postoperatively). Patients should fully understand these risks before surgery and discuss postoperative hormone monitoring plans with a reproductive endocrinologist. If no sperm is found during surgery, alternative paths such as donor sperm or adoption should be planned in advance.
This content is based on clinical consensus in assisted reproductive medicine and practices at Hong Kong fertility centers. It does not constitute individual medical advice. Please consult a reproductive specialist for specific diagnosis and treatment plans.
0 comments